These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 11795947

  • 1. Electrochemical monitoring of anticancer compounds on the human ovarian carcinoma cell line A2780 and its adriamycin- and Cisplatin-resistant variants.
    Woolley DE, Tetlow LC, Adlam DJ, Gearey D, Eden RD, Ward TH, Allen TD.
    Exp Cell Res; 2002 Feb 01; 273(1):65-72. PubMed ID: 11795947
    [Abstract] [Full Text] [Related]

  • 2. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines.
    Manetta A, Gamboa G, Nasseri A, Podnos YD, Emma D, Dorion G, Rawlings L, Carpenter PM, Bustamante A, Patel J, Rideout D.
    Gynecol Oncol; 1996 Feb 01; 60(2):203-12. PubMed ID: 8631539
    [Abstract] [Full Text] [Related]

  • 3. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
    Horowitz NS, Hua J, Gibb RK, Mutch DG, Herzog TJ.
    Gynecol Oncol; 2004 Jul 01; 94(1):67-73. PubMed ID: 15262121
    [Abstract] [Full Text] [Related]

  • 4. Characteristics of homocysteine-induced multidrug resistance of human MCF-7 breast cancer cells and human A2780 ovarian cancer cells.
    Lukyanova NY.
    Exp Oncol; 2010 Mar 01; 32(1):10-4. PubMed ID: 20332764
    [Abstract] [Full Text] [Related]

  • 5. [Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways].
    Wang Y, Li LZ, Ye L, Niu XL, Liu X, Zhu YQ, Sun WJ, Liang YJ.
    Zhonghua Fu Chan Ke Za Zhi; 2010 Sep 01; 45(9):691-8. PubMed ID: 21092551
    [Abstract] [Full Text] [Related]

  • 6. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
    Ma JJ, Chen BL, Xin XY.
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct 01; 146(2):222-6. PubMed ID: 19758744
    [Abstract] [Full Text] [Related]

  • 7. In vitro cytotoxic activity of Taxol and Taxotere on primary cultures and established cell lines of human ovarian cancer.
    Silvestrini R, Zaffaroni N, Orlandi L, Oriana S.
    Stem Cells; 1993 Nov 01; 11(6):528-35. PubMed ID: 7906583
    [Abstract] [Full Text] [Related]

  • 8. Electrochemical monitoring of cell behaviour in vitro: a new technology.
    Woolley DE, Tetlow LC, Adlam DJ, Gearey D, Eden RD.
    Biotechnol Bioeng; 2002 Mar 30; 77(7):725-33. PubMed ID: 11835133
    [Abstract] [Full Text] [Related]

  • 9. Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in A2780/S and A2780/PDD cells.
    Han I, Ling YH, al-Baker S, Khokhar AR, Perez-Soler R.
    Cancer Res; 1993 Oct 15; 53(20):4913-9. PubMed ID: 8402681
    [Abstract] [Full Text] [Related]

  • 10. Taxane sensitivity of ovarian carcinoma in vitro.
    Engblom P, Rantanen V, Kulmala J, Heiskanen J, Grenman S.
    Anticancer Res; 1997 Oct 15; 17(4A):2475-9. PubMed ID: 9252666
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Radiotherapy as a cisplatin-sensitizer in a resistant ovarian carcinoma cell line.
    Siler DF, Wheeless CR, Dubin NH.
    Cancer; 1996 May 01; 77(9):1850-3. PubMed ID: 8646684
    [Abstract] [Full Text] [Related]

  • 13. Downregulation of gene MDR1 by shRNA to reverse multidrug-resistance of ovarian cancer A2780 cells.
    Zhang H, Wang J, Cai K, Jiang L, Zhou D, Yang C, Chen J, Chen D, Dou J.
    J Cancer Res Ther; 2012 May 01; 8(2):226-31. PubMed ID: 22842366
    [Abstract] [Full Text] [Related]

  • 14. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W, Chaney SG.
    Cancer Res; 1993 Feb 15; 53(4):799-805. PubMed ID: 8428361
    [Abstract] [Full Text] [Related]

  • 15. Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.
    Kelland LR, Abel G.
    Cancer Chemother Pharmacol; 1992 Feb 15; 30(6):444-50. PubMed ID: 1356649
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vivo model development of cisplatin-resistant and -sensitive A2780 human ovarian carcinomas.
    Rose WC, Basler GA.
    In Vivo; 1990 Feb 15; 4(6):391-6. PubMed ID: 2103379
    [Abstract] [Full Text] [Related]

  • 18. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.
    Frankel A, Man S, Elliott P, Adams J, Kerbel RS.
    Clin Cancer Res; 2000 Sep 15; 6(9):3719-28. PubMed ID: 10999766
    [Abstract] [Full Text] [Related]

  • 19. [Study of bcl-2 antisense oligodeoxynucleotides on reversal of cisplatin resistance in ovarian cancer cell line A2780/DDP].
    Li M, Yu LL, Cai LQ, Wang HB, Wang ZH, Wang ZH.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb 15; 41(2):121-5. PubMed ID: 16640863
    [Abstract] [Full Text] [Related]

  • 20. Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines.
    Wang W, Ke S, Chen G, Gao Q, Wu S, Wang S, Zhou J, Yang X, Lu Y, Ma D.
    Oncol Rep; 2004 Dec 15; 12(6):1365-70. PubMed ID: 15547764
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.